Literature DB >> 2906068

The natural history of tardive dyskinesia.

G Gardos1, J O Cole, D Haskell, D Marby, S S Paine, P Moore.   

Abstract

Follow-up data from the first 100 patients with early dyskinesia are presented. After an average of 40.9 months, the cohort showed statistically significant decreases in tardive dyskinesia (TD) ratings. After TD onset, ratings decreased for 4 years, then plateaued and rose during the 7th year. Age was not a negative prognostic factor in this cohort. Improvement in TD correlated significantly with fewer neuroleptic-free periods before and more neuroleptic-free periods after TD onset. Neuroleptic dosage correlated negatively with improvement in trunk and dystonia ratings. Improvement in TD is the usual finding in longitudinal studies of TD cohorts. Follow-up studies of neuroleptic-treated groups with varying proportions of patients showing TD, by contrast, tend to show increased TD because new TD cases more than offset improvement. A naturalistic study with pharmacotherapy tailored to the underlying psychiatric disorder and conducted long-term from TD onset is the ideal design for investigating the natural history of TD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906068

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  6 in total

1.  Early dyskinesia--vulnerability.

Authors:  J O Cole; G Gardos; L A Boling; D Marby; D Haskell; P Moore
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors.

Authors: 
Journal:  CMAJ       Date:  1995-05-01       Impact factor: 8.262

3.  Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors.

Authors: 
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

4.  Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study.

Authors:  J S Paulsen; M P Caligiuri; B Palmer; L A McAdams; D V Jeste
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

Review 5.  Tardive dyskinesia.

Authors:  D E Casey
Journal:  West J Med       Date:  1990-11

Review 6.  Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.

Authors:  Hanna Bergman; John Rathbone; Vivek Agarwal; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.